MISSISSAUGA, Canada – September 19, 2008 – YM BioSciences Inc. (AMEX: YMI, TSX: YM, AIM: YMBA), an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today reported operational and financial results for its fiscal 2008 year end, ended June 30, 2008.
